Patent-pending enzymes to break down common dietary triggers
At Kiwi Biosciences, we’re redefining what’s possible for the 15% of people living with Irritable Bowel Syndrome (IBS). Our mission? To let them enjoy meals without fear or discomfort. Through groundbreaking, patent-pending enzyme technology, we tackle common digestive triggers—starting with FODMAPs.
Our flagship product, FODZYME, is a dietary supplement that empowers people to comfortably enjoy foods like garlic, onion, and wheat. For our customers, it’s more than a supplement—it’s transformative, just read our reviews here. IBS isn’t just a medical issue; it impacts the ability to share and enjoy life’s most universal pleasure: food.
Since launching in 2021, FODZYME has reached tens of thousands of people worldwide, with hundreds of new customers joining daily. Our product is endorsed by leading clinicians, featured in peer-reviewed research, and spotlighted by major media like The New York Times. We’ve come far, but we’re just getting started.
After graduating from Y Combinator and Harvard Innovation Labs, we’ve scaled profitably and are gearing up for ambitious growth. Now, we’re seeking a Creative Strategist to elevate our direct-to-consumer marketing, drive paid ad performance, and help shape the voice of a brand that’s changing lives.
Please reply with brief video introduction and CV/resume.
Kiwi Biosciences allows the 15% of the population suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without feeling like their intestines will explode. We develop novel patent-pending enzymes that break down common digestive triggers (starting with the FODMAP family of fermentable carbohydrates). Our first product FODZYME is a dietary supplement that enables folks to comfortably eat garlic, onion, wheat, and much more. Living with IBS isn't just a medical issue because not being able to eat the foods you love severely impacts quality of life. That's why for our customers, the product is magical. We launched FODZYME in 2021 and now serve tens of thousands of customers across the globe. Harvard-trained founders Anjie and David know firsthand how much the underserved IBS community needs this product: Anjie as a patient who developed FODZYME to solve her own gut problems and David who previously sold an IBS digital health company. FODZYME's research has been presented at leading GI conferences and published in a peer-reviewed journal. Join us to make food painless for the millions of people out there who need FODZYME!